Jama-Journal of the American Medical Association最新文献

筛选
英文 中文
Parenthood and Paychecks-The Gender Pay Gap in Medicine. 为人父母与薪水--医学界的性别薪酬差距》(Parenthood and Paychecks-The Gender Pay Gap in Medicine)。
IF 63.1 1区 医学
Jama-Journal of the American Medical Association Pub Date : 2024-10-29 DOI: 10.1001/jama.2024.22123
Kyung Mi Kim, Aditya Narayan, Nirav R Shah, Arnold Milstein
{"title":"Parenthood and Paychecks-The Gender Pay Gap in Medicine.","authors":"Kyung Mi Kim, Aditya Narayan, Nirav R Shah, Arnold Milstein","doi":"10.1001/jama.2024.22123","DOIUrl":"https://doi.org/10.1001/jama.2024.22123","url":null,"abstract":"","PeriodicalId":54909,"journal":{"name":"Jama-Journal of the American Medical Association","volume":" ","pages":""},"PeriodicalIF":63.1,"publicationDate":"2024-10-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142523731","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Ovarian Aging and Fertility. 卵巢衰老与生育能力
IF 63.1 1区 医学
Jama-Journal of the American Medical Association Pub Date : 2024-10-29 DOI: 10.1001/jama.2024.18207
David B Seifer, Eve C Feinberg, Albert L Hsu
{"title":"Ovarian Aging and Fertility.","authors":"David B Seifer, Eve C Feinberg, Albert L Hsu","doi":"10.1001/jama.2024.18207","DOIUrl":"https://doi.org/10.1001/jama.2024.18207","url":null,"abstract":"","PeriodicalId":54909,"journal":{"name":"Jama-Journal of the American Medical Association","volume":" ","pages":""},"PeriodicalIF":63.1,"publicationDate":"2024-10-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142523730","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Myocardial Fibrosis and Timing of Intervention for Aortic Stenosis. 心肌纤维化与介入治疗主动脉瓣狭窄的时机
IF 63.1 1区 医学
Jama-Journal of the American Medical Association Pub Date : 2024-10-28 DOI: 10.1001/jama.2024.22853
Robert O Bonow
{"title":"Myocardial Fibrosis and Timing of Intervention for Aortic Stenosis.","authors":"Robert O Bonow","doi":"10.1001/jama.2024.22853","DOIUrl":"https://doi.org/10.1001/jama.2024.22853","url":null,"abstract":"","PeriodicalId":54909,"journal":{"name":"Jama-Journal of the American Medical Association","volume":" ","pages":""},"PeriodicalIF":63.1,"publicationDate":"2024-10-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142523729","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Early Intervention in Patients With Asymptomatic Severe Aortic Stenosis and Myocardial Fibrosis: The EVOLVED Randomized Clinical Trial. 早期干预无症状重度主动脉瓣狭窄和心肌纤维化患者:EVOLVED 随机临床试验。
IF 63.1 1区 医学
Jama-Journal of the American Medical Association Pub Date : 2024-10-28 DOI: 10.1001/jama.2024.22730
Krithika Loganath, Neil J Craig, Russell J Everett, Rong Bing, Vasiliki Tsampasian, Patrycja Molek, Simona Botezatu, Saadia Aslam, Steff Lewis, Catriona Graham, Audrey C White, Tom MacGillivray, Christopher E Tuck, Phillip Rayson, Denise Cranley, Sian Irvine, Ruth Armstrong, Lynsey Milne, Calvin W L Chin, Graham S Hillis, Timothy Fairbairn, John P Greenwood, Richard Steeds, Stephen J Leslie, Chim C Lang, Chiara Bucciarelli-Ducci, Nikhil V Joshi, Vijay Kunadian, Vassilios S Vassiliou, Jason N Dungu, Sandeep S Hothi, Nicholas Boon, Sanjay K Prasad, Niall G Keenan, Dana Dawson, Thomas A Treibel, Mani Motwani, Christopher A Miller, Nicholas L Mills, Ronak Rajani, David P Ripley, Gerry P McCann, Bernard Prendergast, Anvesha Singh, David E Newby, Marc R Dweck
{"title":"Early Intervention in Patients With Asymptomatic Severe Aortic Stenosis and Myocardial Fibrosis: The EVOLVED Randomized Clinical Trial.","authors":"Krithika Loganath, Neil J Craig, Russell J Everett, Rong Bing, Vasiliki Tsampasian, Patrycja Molek, Simona Botezatu, Saadia Aslam, Steff Lewis, Catriona Graham, Audrey C White, Tom MacGillivray, Christopher E Tuck, Phillip Rayson, Denise Cranley, Sian Irvine, Ruth Armstrong, Lynsey Milne, Calvin W L Chin, Graham S Hillis, Timothy Fairbairn, John P Greenwood, Richard Steeds, Stephen J Leslie, Chim C Lang, Chiara Bucciarelli-Ducci, Nikhil V Joshi, Vijay Kunadian, Vassilios S Vassiliou, Jason N Dungu, Sandeep S Hothi, Nicholas Boon, Sanjay K Prasad, Niall G Keenan, Dana Dawson, Thomas A Treibel, Mani Motwani, Christopher A Miller, Nicholas L Mills, Ronak Rajani, David P Ripley, Gerry P McCann, Bernard Prendergast, Anvesha Singh, David E Newby, Marc R Dweck","doi":"10.1001/jama.2024.22730","DOIUrl":"10.1001/jama.2024.22730","url":null,"abstract":"<p><strong>Importance: </strong>Development of myocardial fibrosis in patients with aortic stenosis precedes left ventricular decompensation and is associated with an adverse long-term prognosis.</p><p><strong>Objective: </strong>To investigate whether early valve intervention reduced the incidence of all-cause death or unplanned aortic stenosis-related hospitalization in asymptomatic patients with severe aortic stenosis and myocardial fibrosis.</p><p><strong>Design, setting, and participants: </strong>This prospective, randomized, open-label, masked end point trial was conducted between August 2017 and October 2022 at 24 cardiac centers across the UK and Australia. Asymptomatic patients with severe aortic stenosis and myocardial fibrosis were included. The final date of follow-up was July 26, 2024.</p><p><strong>Intervention: </strong>Early valve intervention with transcatheter or surgical aortic valve replacement or guideline-directed conservative management.</p><p><strong>Main outcomes and measures: </strong>The primary outcome was a composite of all-cause death or unplanned aortic stenosis-related hospitalization in a time-to-first-event intention-to-treat analysis. There were 9 secondary outcomes, including the components of the primary outcome and symptom status at 12 months.</p><p><strong>Results: </strong>The trial enrolled 224 eligible patients (mean [SD] age, 73 [9] years; 63 women [28%]; mean [SD] aortic valve peak velocity of 4.3 [0.5] m/s) of the originally planned sample size of 356 patients. The primary end point occurred in 20 of 113 patients (18%) in the early intervention group and 25 of 111 patients (23%) in the guideline-directed conservative management group (hazard ratio, 0.79 [95% CI, 0.44-1.43]; P = .44; between-group difference, -4.82% [95% CI, -15.31% to 5.66%]). Of 9 prespecified secondary end points, 7 showed no significant difference. All-cause death occurred in 16 of 113 patients (14%) in the early intervention group and 14 of 111 (13%) in the guideline-directed group (hazard ratio, 1.22 [95% CI, 0.59-2.51]) and unplanned aortic stenosis hospitalization occurred in 7 of 113 patients (6%) and 19 of 111 patients (17%), respectively (hazard ratio, 0.37 [95% CI, 0.16-0.88]). Early intervention was associated with a lower 12-month rate of New York Heart Association class II-IV symptoms than guideline-directed conservative management (21 [19.7%] vs 39 [37.9%]; odds ratio, 0.37 [95% CI, 0.20-0.70]).</p><p><strong>Conclusions and relevance: </strong>In asymptomatic patients with severe aortic stenosis and myocardial fibrosis, early aortic valve intervention had no demonstrable effect on all-cause death or unplanned aortic stenosis-related hospitalization. The trial had a wide 95% CI around the primary end point, with further research needed to confirm these findings.</p><p><strong>Trial registration: </strong>ClinicalTrials.gov Identifier: NCT03094143.</p>","PeriodicalId":54909,"journal":{"name":"Jama-Journal of the American Medical Association","volume":" ","pages":""},"PeriodicalIF":63.1,"publicationDate":"2024-10-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11519785/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142523728","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Community-Acquired Pneumonia: A Review. 社区获得性肺炎:综述。
IF 63.1 1区 医学
Jama-Journal of the American Medical Association Pub Date : 2024-10-15 DOI: 10.1001/jama.2024.14796
Valerie M Vaughn, Robert P Dickson, Jennifer K Horowitz, Scott A Flanders
{"title":"Community-Acquired Pneumonia: A Review.","authors":"Valerie M Vaughn, Robert P Dickson, Jennifer K Horowitz, Scott A Flanders","doi":"10.1001/jama.2024.14796","DOIUrl":"10.1001/jama.2024.14796","url":null,"abstract":"<p><strong>Importance: </strong>Community-acquired pneumonia (CAP) results in approximately 1.4 million emergency department visits, 740 000 hospitalizations, and 41 000 deaths in the US annually.</p><p><strong>Observations: </strong>Community-acquired pneumonia can be diagnosed in a patient with 2 or more signs (eg, temperature >38 °C or ≤36 °C; leukocyte count <4000/μL or >10 000/μL) or symptoms (eg, new or increased cough or dyspnea) of pneumonia in conjunction with consistent radiographic findings (eg, air space density) without an alternative explanation. Up to 10% of patients with CAP are hospitalized; of those, up to 1 in 5 require intensive care. Older adults (≥65 years) and those with underlying lung disease, smoking, or immune suppression are at highest risk for CAP and complications of CAP, including sepsis, acute respiratory distress syndrome, and death. Only 38% of patients hospitalized with CAP have a pathogen identified. Of those patients, up to 40% have viruses identified as the likely cause of CAP, with Streptococcus pneumoniae identified in approximately 15% of patients with an identified etiology of the pneumonia. All patients with CAP should be tested for COVID-19 and influenza when these viruses are common in the community because their diagnosis may affect treatment (eg, antiviral therapy) and infection prevention strategies. If test results for influenza and COVID-19 are negative or when the pathogens are not likely etiologies, patients can be treated empirically to cover the most likely bacterial pathogens. When selecting empirical antibacterial therapy, clinicians should consider disease severity and evaluate the likelihood of a bacterial infection-or resistant infection-and risk of harm from overuse of antibacterial drugs. Hospitalized patients without risk factors for resistant bacteria can be treated with β-lactam/macrolide combination therapy, such as ceftriaxone combined with azithromycin, for a minimum of 3 days. Systemic corticosteroid administration within 24 hours of development of severe CAP may reduce 28-day mortality.</p><p><strong>Conclusions: </strong>Community-acquired pneumonia is common and may result in sepsis, acute respiratory distress syndrome, or death. First-line therapy varies by disease severity and etiology. Hospitalized patients with suspected bacterial CAP and without risk factors for resistant bacteria can be treated with β-lactam/macrolide combination therapy, such as ceftriaxone combined with azithromycin, for a minimum of 3 days.</p>","PeriodicalId":54909,"journal":{"name":"Jama-Journal of the American Medical Association","volume":" ","pages":"1282-1295"},"PeriodicalIF":63.1,"publicationDate":"2024-10-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142301333","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Supreme Court and the Emergency Medical Treatment and Labor Act-A Dangerous Time for Us All. 最高法院与《紧急医疗和劳动法》--对我们所有人来说都是危险的时刻。
IF 63.1 1区 医学
Jama-Journal of the American Medical Association Pub Date : 2024-10-15 DOI: 10.1001/jama.2024.14868
Michele B Goodwin, Allison M Whelan, Lawrence O Gostin
{"title":"The Supreme Court and the Emergency Medical Treatment and Labor Act-A Dangerous Time for Us All.","authors":"Michele B Goodwin, Allison M Whelan, Lawrence O Gostin","doi":"10.1001/jama.2024.14868","DOIUrl":"10.1001/jama.2024.14868","url":null,"abstract":"","PeriodicalId":54909,"journal":{"name":"Jama-Journal of the American Medical Association","volume":" ","pages":"1233-1234"},"PeriodicalIF":63.1,"publicationDate":"2024-10-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142301348","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prognostic Value of Cardiovascular Biomarkers-Reply. 心血管生物标志物的预后价值--回复。
IF 63.1 1区 医学
Jama-Journal of the American Medical Association Pub Date : 2024-10-15 DOI: 10.1001/jama.2024.16525
Johannes T Neumann, Raphael Twerenbold, Francisco Ojeda
{"title":"Prognostic Value of Cardiovascular Biomarkers-Reply.","authors":"Johannes T Neumann, Raphael Twerenbold, Francisco Ojeda","doi":"10.1001/jama.2024.16525","DOIUrl":"10.1001/jama.2024.16525","url":null,"abstract":"","PeriodicalId":54909,"journal":{"name":"Jama-Journal of the American Medical Association","volume":" ","pages":"1303-1304"},"PeriodicalIF":63.1,"publicationDate":"2024-10-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142301345","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Public Health Crisis in Gaza. 加沙的公共卫生危机。
IF 63.1 1区 医学
Jama-Journal of the American Medical Association Pub Date : 2024-10-15 DOI: 10.1001/jama.2024.16663
Jerome Groopman
{"title":"Public Health Crisis in Gaza.","authors":"Jerome Groopman","doi":"10.1001/jama.2024.16663","DOIUrl":"10.1001/jama.2024.16663","url":null,"abstract":"","PeriodicalId":54909,"journal":{"name":"Jama-Journal of the American Medical Association","volume":" ","pages":"1305"},"PeriodicalIF":63.1,"publicationDate":"2024-10-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142143480","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Fetal Personhood Laws and Their Implications for Health Care. 胎儿人格法及其对医疗保健的影响。
IF 63.1 1区 医学
Jama-Journal of the American Medical Association Pub Date : 2024-10-15 DOI: 10.1001/jama.2024.14739
Carmel Shachar, Lucy Tu, Bhav Jain
{"title":"Fetal Personhood Laws and Their Implications for Health Care.","authors":"Carmel Shachar, Lucy Tu, Bhav Jain","doi":"10.1001/jama.2024.14739","DOIUrl":"10.1001/jama.2024.14739","url":null,"abstract":"","PeriodicalId":54909,"journal":{"name":"Jama-Journal of the American Medical Association","volume":" ","pages":"1231-1232"},"PeriodicalIF":63.1,"publicationDate":"2024-10-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142301339","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Public Health Crisis in Gaza. 加沙的公共卫生危机。
IF 63.1 1区 医学
Jama-Journal of the American Medical Association Pub Date : 2024-10-15 DOI: 10.1001/jama.2024.16660
David Siscovick
{"title":"Public Health Crisis in Gaza.","authors":"David Siscovick","doi":"10.1001/jama.2024.16660","DOIUrl":"10.1001/jama.2024.16660","url":null,"abstract":"","PeriodicalId":54909,"journal":{"name":"Jama-Journal of the American Medical Association","volume":" ","pages":"1304-1305"},"PeriodicalIF":63.1,"publicationDate":"2024-10-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142143479","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信